Literature DB >> 10418738

Inflammation, the acute phase response and atherosclerosis.

J Whicher1, L Biasucci, N Rifai.   

Abstract

There is increasing evidence that atherosclerosis is a chronic inflammatory disorder resulting from a combination of processes, and that acute exacerbations of this inflammation are associated with the acute coronary syndromes such as myocardial infarction and unstable angina. Measurement of the serum level of acute phase proteins, such as C-reactive protein and serum amyloid A protein, has been used to predict the risk of acute events in patients with atherosclerosis. Prospective studies have shown that higher serum acute phase protein levels, often within the reference range, are associated with increased risk of myocardial infarction (MI), stroke or peripheral vascular disease and predict risk of infarction and death among high-risk patients. These observations have important implications for the assessment of patients and for treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10418738     DOI: 10.1515/CCLM.1999.080

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Molecular insights into the progression of crystalline silica-induced pulmonary toxicity in rats.

Authors:  Rajendran Sellamuthu; Christina Umbright; Jenny R Roberts; Amy Cumpston; Walter McKinney; Bean T Chen; David Frazer; Shengqiao Li; Michael Kashon; Pius Joseph
Journal:  J Appl Toxicol       Date:  2012-03-19       Impact factor: 3.446

2.  The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction.

Authors:  Petr Ostadal; David Alan; Petr Hajek; David Horak; Jiri Vejvoda; Jiri Trefanec; Martin Mates; Jan Vojacek
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

3.  Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women.

Authors:  Sudeepa Bhattacharyya; Eric R Siegel; Sara J Achenbach; Sundeep Khosla; Larry J Suva
Journal:  J Bone Miner Res       Date:  2008-07       Impact factor: 6.741

4.  Discovery and verification of urinary peptides in type 2 diabetes mellitus with kidney injury.

Authors:  Guangzhen Fu; Ye Du; Lina Chu; Man Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2016-02-03

5.  Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696].

Authors:  Petr Ostadal; David Alan; Petr Hajek; Jiri Vejvoda; Martin Mates; Peter Blasko; Josef Veselka; Milan Kvapil; Jiri Kettner; Martin Wiendl; Ondrej Aschermann; Josef Slaby; Eduard Nemecek; Frantisek Holm; Marek Rac; Milan Macek; Jana Cepova
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-03-24

Review 6.  Particle-induced pulmonary acute phase response may be the causal link between particle inhalation and cardiovascular disease.

Authors:  Anne T Saber; Nicklas R Jacobsen; Petra Jackson; Sarah Søs Poulsen; Zdenka O Kyjovska; Sabina Halappanavar; Carole L Yauk; Håkan Wallin; Ulla Vogel
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-06-12

7.  Increased high-sensitivity C-reactive protein, erythrocyte sedimentation rate and lactic acid in stroke patients with internal carotid artery occlusion.

Authors:  Dan Xie; Di Hu; Qin Zhang; Yufang Sun; Jimei Li; Yongbo Zhang
Journal:  Arch Med Sci       Date:  2015-01-14       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.